Pertinax provides sustained, controlled antimicrobial protection for medical devices, biomaterials and in topical formulations.
Pertinax Pharma are supported by an experienced management team and a highly skilled and versatile team of scientists.
Get in touch to learn more about our technology and to discuss how Pertinax might be used in your products.
Get In Touch
About Pertinax Pharma
Pertinax formed in 2015, as a spin-out from the University of Bristol. The technology was initially developed in the laboratory of Dr Michele Barbour, CEO. Michele is supported by an experienced management team and a dynamic and dedicated team of scientists.
Find out the latest news and information from Pertinax.
A team of academics from Oxford Brookes’ Centre for Diversity Policy Research and Practice have conducted a study of representation of women in spin-outs, from founding, to board representation, CEO and other leadership positions, and other … Read More about Michele speaks at “Women in Spinouts” Event, Oxford Brookes University
To help drive expansion into new global markets, Pertinax Pharma has bolstered its commercial team with the appointment of Paul Williams as Business Development Manager. Currently undertaking his MBA Global at the University of Derby, … Read More about Pertinax Pharma appoint Paul Williams as Business Development Manager
The company is delighted to formally launch its Pertinax technology. Coverage of our launch can be found here, here and here. October 2017. … Read More about Pertinax Pharma announce commercial launch